JP2020505465A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020505465A5 JP2020505465A5 JP2019560493A JP2019560493A JP2020505465A5 JP 2020505465 A5 JP2020505465 A5 JP 2020505465A5 JP 2019560493 A JP2019560493 A JP 2019560493A JP 2019560493 A JP2019560493 A JP 2019560493A JP 2020505465 A5 JP2020505465 A5 JP 2020505465A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- chain variable
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1701194.1 | 2017-01-24 | ||
| GBGB1701194.1A GB201701194D0 (en) | 2017-01-24 | 2017-01-24 | Antigen binding molecules that bind light |
| PCT/GB2018/050203 WO2018138496A1 (en) | 2017-01-24 | 2018-01-24 | Antigen binding molecules that bind light |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020505465A JP2020505465A (ja) | 2020-02-20 |
| JP2020505465A5 true JP2020505465A5 (enExample) | 2021-03-11 |
| JP7140403B2 JP7140403B2 (ja) | 2022-09-21 |
Family
ID=58463068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019560493A Active JP7140403B2 (ja) | 2017-01-24 | 2018-01-24 | Ｌｉｇｈｔに結合する抗原結合分子 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11827673B2 (enExample) |
| EP (1) | EP3574014A1 (enExample) |
| JP (1) | JP7140403B2 (enExample) |
| KR (1) | KR20190110578A (enExample) |
| CN (1) | CN110461875B (enExample) |
| GB (2) | GB201701194D0 (enExample) |
| WO (1) | WO2018138496A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114516913B (zh) * | 2020-11-19 | 2023-04-28 | 东莞市朋志生物科技有限公司 | 抗n末端脑钠肽前体的抗体和检测试剂盒 |
| CN116355860A (zh) * | 2021-12-28 | 2023-06-30 | 四川远大蜀阳药业有限责任公司 | 分泌抗h因子抗体的杂交瘤细胞株、抗h因子抗体及其应用 |
| WO2025195445A1 (zh) * | 2024-03-21 | 2025-09-25 | 北京三诺佳邑生物技术有限责任公司 | 特异性结合light和tslp的多特异性抗体以及组合物及其应用 |
| KR20250151071A (ko) | 2024-04-13 | 2025-10-21 | 백수경 | 이동식 방제 박스 |
| US20260062472A1 (en) * | 2024-08-28 | 2026-03-05 | Earendil Labs Inc. | Bispecific antibody and use thereof |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3734795A (en) | 1971-04-23 | 1973-05-22 | Lindsay Wire Weaving Co | Patch and seam for plastic belts |
| US6635743B1 (en) | 1996-03-22 | 2003-10-21 | Human Genome Sciences, Inc. | Apoptosis inducing molecule II and methods of use |
| US7964190B2 (en) | 1996-03-22 | 2011-06-21 | Human Genome Sciences, Inc. | Methods and compositions for decreasing T-cell activity |
| EP0985033A4 (en) | 1997-04-04 | 2005-07-13 | Biosite Inc | POLYVALENT AND POLYCLONAL LIBRARIES |
| US6140467A (en) | 1997-07-07 | 2000-10-31 | La Jolla Institute For Allergy And Immunology | Ligand for herpes simplex virus entry mediator and methods of use |
| US6998108B1 (en) | 1997-07-07 | 2006-02-14 | La Jolla Institute For Allergy And Immunology | Antibodies to p30 polypeptides and methods making and using same |
| US7118742B2 (en) | 1997-07-07 | 2006-10-10 | La Jolla Institute For Allergy And Immunology | Ligand for herpes simplex virus entry mediator and methods of use |
| ATE365214T1 (de) | 2000-04-12 | 2007-07-15 | Jolla Inst Allergy Immunolog | Ligand des zelleintritt-vermittelnden proteins von herpes simplex und methoden zu dessen verwendungen |
| EP1336619A3 (en) | 2002-02-19 | 2003-12-10 | Millenium Pharmaceuticals, Inc. | Combination of a HVEM-LIGHT inhibitor and an immunosuppressive agent in the treatment or prevention of immune disorders |
| WO2003089575A2 (en) * | 2002-04-15 | 2003-10-30 | Human Genome Sciences, Inc. | Antibodies that specifically bind to tl5 |
| EP2484696B1 (en) * | 2006-08-28 | 2017-08-16 | Kyowa Hakko Kirin Co., Ltd. | Antagonistic hLIGHT-specific human monoclonal antibodies |
| ZA200901165B (en) * | 2006-08-28 | 2010-06-30 | Kyowa Hakko Kirin Co Ltd | Antagonistic human light-specific human monoclonal antibodies |
| US8440185B2 (en) | 2006-12-26 | 2013-05-14 | The Johns Hopkins University | Compositions and methods for the treatment of immunologic disorders |
| AU2008255352B2 (en) | 2007-05-31 | 2014-05-22 | Genmab A/S | Stable IgG4 antibodies |
| EP3750554A3 (en) | 2007-09-18 | 2021-07-28 | La Jolla Institute for Allergy and Immunology | Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment |
| JP2012507299A (ja) * | 2008-10-31 | 2012-03-29 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | Ｌｉｇｈｔ標的分子およびその使用 |
| WO2010111180A1 (en) | 2009-03-24 | 2010-09-30 | Teva Biopharmaceuticals Usa, Inc. | Humanized antibodies against light and uses thereof |
| US9592289B2 (en) | 2012-03-26 | 2017-03-14 | Sanofi | Stable IgG4 based binding agent formulations |
| JP6265970B2 (ja) * | 2012-03-26 | 2018-01-24 | サノフイ | 安定なＩｇＧ４に基づく結合剤の製剤 |
| US20130315913A1 (en) * | 2012-03-26 | 2013-11-28 | Sanofi | Anti-light antibody therapy for inflammatory bowel disease |
| AU2014318014C1 (en) | 2013-09-06 | 2018-11-15 | Research Development Foundation | Alpha-tea salt forms: compositions and uses for treating disease |
| WO2015061752A1 (en) | 2013-10-25 | 2015-04-30 | Pharmacyclics, Inc. | Treatment using bruton's tyrosine kinase inhibitors and immunotherapy |
| JP2017504327A (ja) | 2014-01-14 | 2017-02-09 | カイマブ・リミテッド | 抗ｌｉｇｈｔ抗体 |
| WO2015155738A2 (en) | 2014-04-09 | 2015-10-15 | Christopher Rudd | Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity |
| US20180016345A1 (en) | 2015-02-05 | 2018-01-18 | La Jolla Institute For Allergy And Immunology | Light inhibitors for scleroderma and skin fibrotic disease treatment |
| HK1257443A1 (zh) | 2015-08-21 | 2019-10-18 | The Children's Hospital Of Philadelphia | 治疗具有dcr3或dcr3网络基因中的遗传变异的患者的自身免疫病症的方法 |
| US11312781B2 (en) * | 2018-01-24 | 2022-04-26 | Capella Bioscience Ltd. | Antigen binding molecules that bind LIGHT |
-
2017
- 2017-01-24 GB GBGB1701194.1A patent/GB201701194D0/en not_active Ceased
-
2018
- 2018-01-24 WO PCT/GB2018/050203 patent/WO2018138496A1/en not_active Ceased
- 2018-01-24 JP JP2019560493A patent/JP7140403B2/ja active Active
- 2018-01-24 EP EP18702792.5A patent/EP3574014A1/en active Pending
- 2018-01-24 GB GB1820446.1A patent/GB2566389B/en active Active
- 2018-01-24 KR KR1020197024448A patent/KR20190110578A/ko not_active Abandoned
- 2018-01-24 CN CN201880019587.7A patent/CN110461875B/zh active Active
- 2018-01-24 US US16/480,367 patent/US11827673B2/en active Active
-
2023
- 2023-10-03 US US18/480,379 patent/US20240294655A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109195993B (zh) | 串联fab免疫球蛋白及其用途 | |
| JP2020513791A5 (enExample) | ||
| AU2015322141B2 (en) | High affinity and aggregatively stable antibodies on the basis of variable domains Vl and a derivative VHH | |
| JP2014534218A5 (enExample) | ||
| TW201833141A (zh) | 抗b7-h3抗體、其抗原結合片段及其醫藥用途 | |
| JP2012501670A5 (enExample) | ||
| HRP20191219T1 (hr) | Molekule protutijela koje imaju specifičnost za ljudski ox40 | |
| JP2012524071A5 (enExample) | ||
| HRP20170041T1 (hr) | Anti-c5a vezujuće grupe s visokom blokirajućom aktivnošću | |
| JP2011509245A5 (enExample) | ||
| JP2010526028A5 (enExample) | ||
| JP2014500009A5 (enExample) | ||
| EP4267615A1 (en) | Antibody variable domains that bind il-4r | |
| CA2896548A1 (en) | Multivalent binding protein compositions | |
| JP2025500971A5 (enExample) | ||
| CN114144431B (zh) | 人源化抗TNFα抗体及其用途 | |
| JP2011207882A5 (enExample) | ||
| JP2014519334A5 (enExample) | ||
| JP2012531922A5 (ja) | Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位 | |
| JP2015537190A5 (enExample) | ||
| WO2015191934A2 (en) | Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases | |
| JP2016520595A5 (enExample) | ||
| JP2024532495A (ja) | 抗ヒトｔｓｌｐモノクローナル抗体及びその使用 | |
| JP2012514458A5 (enExample) | ||
| RU2014114015A (ru) | Способы лечения воспалительных расстройств с использованием антител против m-csf |